[REGN] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
03-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- 54.41%
YoY- -19.39%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 3,158,100 3,162,100 3,414,400 2,936,200 2,857,200 2,965,100 4,951,700 -25.96%
PBT 1,082,900 858,000 1,324,700 1,509,800 963,200 1,061,100 2,503,400 -42.89%
Tax 114,500 40,200 127,600 194,100 111,100 87,600 274,400 -44.24%
NP 968,400 817,800 1,197,100 1,315,700 852,100 973,500 2,229,000 -42.72%
Tax Rate -10.57% -4.69% -9.63% -12.86% -11.53% -8.26% -10.96% -
Total Cost 2,189,700 2,344,300 2,217,300 1,620,500 2,005,100 1,991,600 2,722,700 -13.55%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin 30.66 25.86 35.06 44.81 29.82 32.83 45.01 -22.63%
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS 9.05 7.64 11.19 11.66 7.47 8.61 20.99 -43.01%
EPS Diluted 8.50 7.17 10.50 11.66 7.47 8.61 19.69 -42.96%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.